Cortagen peptide: 5 things most articles get wrong

Most articles call Cortagen a thymus peptide. It is not. It comes out of cerebral cortex research, its headline mortality data belongs to a different compound, and its own evidence is preclinical and about nerves.

Published · Updated · 9 min read
TL;DR
  • Cortagen (Ala-Glu-Asp-Pro) comes out of cerebral cortex research at the St. Petersburg Institute of Bioregulation and Gerontology. It is not a thymus peptide.
  • The widely quoted 2 to 4-fold mortality reduction comes from a 2003 study of Thymalin and Epithalamin, two different compounds. It is not Cortagen data.
  • Cortexin, a cortex extract approved as a medicine in Russia, is not the same thing as Cortagen, a single four-amino-acid sequence.
  • Cortagen's most specific findings are preclinical and concern peripheral nerve regeneration. No independent human trial of Cortagen exists.
  • Cortagen is not approved by the FDA for any use, and no study has tested whether any genotype changes response to it.

Many English-language articles on Cortagen get the same thing wrong in the first sentence: they call it a thymus peptide. Cortagen (Ala-Glu-Asp-Pro) comes out of cerebral cortex research, the outer layer of the brain where thinking and voluntary movement are organised, at the St. Petersburg Institute of Bioregulation and Gerontology. The misidentification carries a lot with it: the immune data, the T-cell claims and the famous mortality figures all belong to a different peptide from the same lab.

This page sets out what is and is not known about Cortagen. It is a summary of research, not a recommendation; Cortagen is not approved by the FDA for any use.

775

Peer-reviewed papers published by Vladimir Khavinson and colleagues at the St. Petersburg Institute since 1977. Six peptide bioregulators from this work have been registered as medicines in Russia. Cortagen is not one of them.

In plain English

The Khavinson bioregulators are short peptides, each derived from a specific tissue (thymus, pineal gland, liver, blood vessels, cerebral cortex) and proposed to act on the cells of that organ. Thymalin comes from thymus tissue and was studied for immune effects. Cortagen comes from cerebral cortex research. Same research programme, different organs.

The Corrections

What most articles about Cortagen get wrong

1. Cortagen is not a thymus peptide

The Khavinson series includes different peptides for different organs. The thymus ones are Thymalin (a mixed extract of thymus tissue) and Thymogen (a two-amino-acid synthetic, Glu-Trp). Cortagen's sequence is Ala-Glu-Asp-Pro (AEDP), and it comes from research on Cortexin, a cerebral cortex extract.

If an article says Cortagen supports thymus function or restores T-cell ratios, it is either describing Thymalin under the wrong name or mixing up two compounds from the same lab.

2. The famous mortality data belongs to Thymalin and Epithalamin, not Cortagen

The most quoted statistic in Cortagen discussions is a 2 to 4-fold reduction in mortality in older adults over 6 to 8 years. That finding comes from a different study.

"[Thymalin and Epithalamin] resulted in a 2.5-fold reduction in death rate compared to controls. Extended administration over 6 years produced a 4.1-fold reduction in mortality and a 2.0 to 2.4-fold reduction in acute respiratory infections."

Khavinson VKh and Morozov VG, Neuro Endocrinology Letters, 2003 (PMID 14523363)

The 2003 study followed 266 older adults (mean age 71 to 77) who received Thymalin (thymus extract) and Epithalamin (pineal extract). It came from the same institute that developed the compounds, and it has not been independently replicated. Neither compound is Cortagen, so the result says nothing about Cortagen.

3. Cortagen and Cortexin are not the same thing

Cortexin is a mixture of many small protein fragments extracted from cerebral cortex tissue. It is approved in Russia as a medicine for stroke recovery, head injury and cognitive decline. Cortagen is a single four-amino-acid sequence taken from that research.

Cortexin (cortex extract)

A mixture of many short peptides. Registered as a medicine in Russia. Has Russian clinical trial data. Not approved in the US.

Cortagen (AEDP tetrapeptide)

One synthetic four-amino-acid sequence. Not registered as a medicine in Russia. Not approved by the FDA for any use. Human data comes only from Khavinson's institute; no independent trial exists.

Treating the two as one inflates Cortagen's evidence with Cortexin's clinical record, a common error in forum posts and online marketing copy.

4. The most specific research is preclinical and about peripheral nerves

Cortagen is usually discussed as a cognitive compound. Its most specific published findings are elsewhere. In a 2000 preclinical study of surgically repaired peripheral nerves (Turchaninova and colleagues, Bulletin of Experimental Biology and Medicine), Cortagen was associated with a 27% increase in nerve fibre growth rate and a 40% increase in nerve conduction velocity compared with controls.

A 2011 preclinical paper by Zarubina and Shabanov (Experimental and Clinical Pharmacology) compared Cortagen with Cortexin in a model of chronically reduced blood flow to the brain and found comparable improvements in behaviour and antioxidant markers.

40%

Improvement in nerve conduction velocity after surgical nerve repair in a 2000 preclinical study of Cortagen (Turchaninova et al., Bulletin of Experimental Biology and Medicine). The most specific number in the Cortagen evidence base, and it does not come from people.

These are preclinical results from a small number of studies, most of them from groups linked to the institute that developed the compound. No human trial has tested Cortagen for nerve repair or for cognition outside that institute.

5. How it is proposed to work is a hypothesis

Khavinson's group proposes that very short peptides of two to four amino acids enter the cell nucleus and bind stretches of DNA in front of genes, changing which genes are switched on. A 2012 paper in Advances in Gerontology describes this model. It is the group's own hypothesis, and it has not been independently confirmed for Cortagen.

Genetics

What genetics can and cannot tell you about Cortagen

No published study has tested whether any genotype changes how a person responds to Cortagen. Genes involved in brain signalling, such as BDNF (a growth factor brain cells use to build connections) and COMT (an enzyme that clears dopamine from the front of the brain), carry common variants that have been studied for their links to memory and mood. Those links do not extend to Cortagen, because nobody has tested them against it.

For the pineal peptide from the same programme, the one that was in the 2003 mortality study, see the Epithalon article. For how nasal delivery to the brain has been studied with other peptides, see intranasal peptide absorption.

Status

Regulatory status

Cortagen is not approved by the FDA for any use, and FDA treats products containing it as unapproved drugs when they are marketed for people. In Russia it is not registered as a medicine.

The short version: Cortagen is a cerebral cortex peptide, not a thymus peptide, and much of what circulates about it is borrowed from other compounds. The mortality data belongs to Thymalin and Epithalamin. Cortexin's clinical record belongs to Cortexin. Cortagen's own evidence is preclinical, mostly from the institute that developed it, and concerns nerve regeneration. There is no independent human trial.

ShareXLinkedIn
Your DNA reportSee how your DNA reads the peptides in this guide.Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show. Checked by our team, ready within 24 hours.Upload your DNA, $99No DNA test yet? Order one →

Frequently asked questions

What is Cortagen?

Cortagen (Ala-Glu-Asp-Pro) is a synthetic four-amino-acid peptide from cerebral cortex research at the St. Petersburg Institute of Bioregulation and Gerontology. Its published research is preclinical and mostly from groups linked to that institute. It is not approved by the FDA for any use.

Is Cortagen a thymus peptide?

No. The Khavinson thymus peptides are Thymalin (an extract) and Thymogen (the dipeptide Glu-Trp). Cortagen comes from cerebral cortex research, not thymus research.

Does Cortagen have the same mortality data as Thymalin?

No. The 2 to 4-fold mortality reduction comes from a 2003 study by Khavinson and Morozov in Neuro Endocrinology Letters (PMID 14523363), which followed 266 older adults who received Thymalin and Epithalamin, not Cortagen. That study came from the developing institute and has not been independently replicated.

What did the Cortagen nerve studies find?

In a 2000 preclinical study of surgically repaired nerves (Turchaninova et al., Bulletin of Experimental Biology and Medicine), Cortagen was associated with a 27% increase in nerve fibre growth rate and a 40% increase in nerve conduction velocity compared with controls. No human trial has tested Cortagen for nerve repair.

How is Cortagen different from Cortexin?

Cortexin is a mixture of many short peptides extracted from cerebral cortex tissue and registered as a medicine in Russia for stroke and head injury. Cortagen is a single synthetic four-amino-acid sequence from that research, with a much smaller and mostly preclinical evidence base.

Is Cortagen FDA-approved?

No. Cortagen is not approved by the FDA for any use, and FDA treats products containing it as unapproved drugs when they are marketed for people.

This article is for informational and educational purposes only. It reports what published research found; it is not medical advice, it does not diagnose, treat, cure or prevent any disease, and nothing in it is a dose or a recommendation to use any compound. Talk to a licensed clinician about any medical decision.

Keep reading

Related articles

Peptide GuidesEpithalon and telomere length: what 30 years of research shows, and what it does not10 min readPeptide GuidesThymosin alpha-1: what 30 trials and a failed sepsis study actually showed10 min readPeptide GuidesPinealon peptide: what the Russian research actually shows9 min read
← PreviousPinealon peptide: what the Russian research actually showsPeptide Guides · 9 min readNext →Hexarelin: 7 things the research found, from GH release to a second receptor in the heartPeptide Guides · 9 min read
Upload your DNA